Hong Kong healthcare stocks collectively strengthened, with WuXi AppTec's shares rising more than 5%.

As of the deadline for submission, WuXi AppTec rose by 5.65%, WuXi Biologics rose by 2.78%, and Kanglong Chemical rose by 2.89%. In terms of news, WuXi AppTec announced its performance yesterday, with revenue of 45.456 billion yuan in 2025, an increase of 15.8% year-on-year; net profit of 19.195 billion yuan, an increase of 105.2% year-on-year.